Allakos Inc. (ALLK)
May 15, 2025 - ALLK was delisted (reason: acquired by Concentra Biosciences)
0.3291
-0.0002 (-0.06%)
Inactive · Last trade price
on May 14, 2025
Allakos Employees
Allakos had 131 employees as of December 31, 2023. The number of employees increased by 8 or 6.50% compared to the previous year.
Employees
131
Change (1Y)
8
Growth (1Y)
6.50%
Revenue / Employee
n/a
Profits / Employee
-$540,870
Market Cap
29.74M
Employees Chart
ALLK News
- 6 weeks ago - Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share - GlobeNewsWire
- 2 months ago - Allakos Provides Business Update and Reports Fourth Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - Lycia Therapeutics Announces the Appointment of Chin Lee, MD, MPH, as Chief Medical Officer and Reveals Immunology Pipeline - GlobeNewsWire
- 3 months ago - Kuehn Law Encourages Investors of Allakos Inc. to Contact Law Firm - GlobeNewsWire
- 4 months ago - Why Is Allakos Stock Plunging On Monday? - Benzinga
- 4 months ago - Allakos Announces Topline Results from its Phase 1 Trial of AK006 in Patients with Chronic Spontaneous Urticaria and Announces Restructuring - GlobeNewsWire
- 6 months ago - Allakos Runs Up Into A Near-Term Catalyst - Seeking Alpha
- 6 months ago - Allakos Provides Business Update and Reports Third Quarter 2024 Financial Results - GlobeNewsWire